Responsive electrical stimulation for movement disorders

• US 9,126,042 B2
• Filed: 09/12/2014
• Issued: 09/08/2015
• Est. Priority Date: 02/05/2002
• Status: Expired due to Term

• Current Assignee: Neuropace Inc.
• Original Assignee: Neuropace Inc.
• Inventors: Tcheng, Thomas K., Fischell, Robert E., Pless, Benjamin D.
• Primary Examiner(s): GETZOW, SCOTT M
• Application Number:
  US14/484,701
• Publication Number:
  US 20140379046A1
• Time in Patent Office: 361 Days
• Field of Search: 607/45, 607/62, 600544-546
• US Class Current: 1/1
• CPC Class Codes: A61N 1/36067 Movement disorders, e.g. tremor or Parkinson disease stimulating motor muscle A61N1/36003
• CPC Class Codes: A61N 1/36135 using physiological parameters

Abstract

An implantable neurostimulator system for treating movement disorders includes a sensor, a detection subsystem capable of identifying episodes of a movement disorder by analyzing a signal received from the sensor, and a therapy subsystem capable of supplying therapeutic electrical stimulation to treat the movement disorder. The system treats movement disorders by detecting physiological conditions characteristic of an episode of symptoms of the movement disorder and selectively initiating therapy when such conditions are detected.

Claims

1. An implantable neurostimulator for treating a patient experiencing a movement disorder comprising:

a sensor interface for receiving a first signal from a first sensor configured to sense electrical activity of the brain and a second signal from a second sensor configured to sense motion of the patient;

a detection subsystem for analyzing the first signal and the second signal, the detection subsystem configured to;

measure a frequency of the first signal and a frequency of the second signal,

calculate a frequency offset corresponding to the difference between the frequency of the first signal and the frequency of the second signal,

compare the frequency offset to a frequency criterion,

measure a phase of the first signal and a phase of the second signal;

calculate a phase offset corresponding to the difference between the phase of the first signal and the phase of the second signal,

compare the phase offset to a phase criterion, and

detect a tremor event when both the frequency criterion and the threshold criterion are satisfied; and

a stimulation subsystem configured to deliver a treatment to the patient from the neurostimulator.

2. The implantable neurostimulator of claim 1, wherein the frequency criterion is an offset value and the frequency criterion is satisfied when the frequency offset is within a specified range of the value.

3. The implantable neurostimulator of claim 2, wherein the offset value is near zero.

4. The implantable neurostimulator of claim 1, wherein the phase criterion is an offset constant and the phase criterion is satisfied when the phase offset is within a specified range of the offset constant.

5. The implantable neurostimulator of claim 4, wherein the offset constant is a patient-specific constant.

6. The implantable neurostimulator of claim 1, wherein in order to measure a phase of the first signal and a phase of the second signal, the detection subsystem is further configured to:

determine a first time at which a first landmark of a waveform representative of the first signal occurs; and

determine a second time at which a second landmark of a waveform representative of the second signal occurs, the second landmark being the same type of landmark as the first landmark.

7. The implantable neurostimulator of claim 6, wherein the waveform representative of the first signal comprises a plurality of peaks and the first landmark corresponds to the largest peak of the plurality of peaks, and the waveform representative of the second signal comprises a plurality of peaks and the second landmark correspond to the largest peak of the plurality of peaks.

8. The implantable neurostimulator of claim 1, wherein the first and second signal are continuously received by the sensor interface and continuously analyzed by the detection subsystem.

9. The implantable neurostimulator of claim 8, wherein the stimulation subsystem is configured to:

deliver treatment for so long as the tremor event is detected; and

cease delivery of the treatment when the tremor event is no longer detected.

10. A method for treating a movement disorder in a human patient with an implantable neurostimulator comprising:

receiving a first signal from a first sensor configured to sense electrical activity of the brain;

receiving a second signal from a second sensor configured to sense motion of the patient;

analyzing the first signal and the second signal to determine whether a tremor characteristic of an episode of the movement disorder is occurring, wherein analyzing the first and second signals comprises;

measuring a frequency of the first signal and a frequency of the second signal,

calculating a frequency offset corresponding to the difference between the frequency of the first signal and the frequency of the second signal,

comparing the frequency offset to a frequency criterion,

measuring a phase of the first signal and a phase of the second signal;

calculating a phase offset corresponding to the difference between the phase of the first signal and the phase of the second signal,

comparing the phase offset to a phase criterion, and

detecting a tremor event when both the frequency criterion and the threshold criterion are satisfied; and

delivering a treatment to the patient from the neurostimulator.

11. The method of claim 10, wherein the frequency criterion is an offset value and the frequency criterion is satisfied when the frequency offset is within a specified range of the offset value.

12. The method of claim 11, wherein the offset value is near zero.

13. The method of claim 10, wherein the phase criterion is an offset constant and the phase criterion is satisfied when the phase offset is within a specified range of the offset constant.

14. The method of claim 13, wherein the offset constant is a patient-specific constant.

15. The method of claim 10, wherein measuring a phase of the first signal and a phase of the second signal comprises:

determining a first time at which a first landmark of a waveform representative of the first signal occurs; and

determining a second time at which a second landmark of a waveform representative of the second signal occurs, the second landmark being the same type of landmark as the first landmark.

16. The method of claim 10, wherein the waveform representative of the first signal comprises a plurality of peaks and the first landmark corresponds to the largest peak of the plurality of peaks, and the waveform representative of the second signal comprises a plurality of peaks and the second landmark correspond to the largest peak of the plurality of peaks.

17. The method of claim 10, wherein the first and second signal are continuously received and analyzed.

18. The method of claim 17, wherein the treatment is delivered for so long as the tremor event is detected, the method further comprising ceasing delivery of the treatment when the tremor event is no longer detected.